|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh
Z, Khoudari G, Sarmini MT, Gad M, Al-Husseini M and Saad A:
Colorectal cancer epidemiology: Recent trends and impact on
outcomes. Curr Drug Targets. 22:998–1009. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xia C, Dong X, Li H, Cao M, Sun D, He S,
Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China
and United States, 2022: Profiles, trends, and determinants. Chin
Med J (Engl). 135:584–590. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu X, Lin H and Li S: Prognoses of
different pathological subtypes of colorectal cancer at different
stages: A population-based retrospective cohort study. BMC
Gastroenterol. 19:1642019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanth P and Inadomi JM: Screening and
prevention of colorectal cancer. BMJ. 374:n18552021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martinez-Reyes I and Chandel NS: Cancer
metabolism: Looking forward. Nat Rev Cancer. 21:669–680. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vander Heiden MG and DeBerardinis RJ:
Understanding the intersections between metabolism and cancer
biology. Cell. 168:657–669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Klassen A, Faccio AT, Canuto GA, da Cruz
PL, Ribeiro HC, Tavares MF and Sussulini A: Metabolomics:
Definitions and significance in systems biology. Adv Exp Med Biol.
965:3–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gold A, Choueiry F, Jin N, Mo X and Zhu J:
The Application of metabolomics in recent colorectal cancer
studies: A state-of-the-art review. Cancers (Basel). 14:7252022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Erben V, Bhardwaj M, Schrotz-King P and
Brenner H: Metabolomics biomarkers for detection of colorectal
neoplasms: A systematic review. Cancers (Basel). 10:2462018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hashim NAA, Ab-Rahim S, Suddin LS, Saman
MSA and Mazlan M: Global serum metabolomics profiling of colorectal
cancer. Mol Clin Oncol. 11:3–14. 2019.PubMed/NCBI
|
|
14
|
Di Giovanni N, Meuwis MA, Louis E and
Focant JF: Specificity of metabolic colorectal cancer biomarkers in
serum through effect size. Metabolomics. 16:882020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen Y, Sun M, Zhu J, Wei M, Li H, Zhao P,
Wang J, Li R, Tian L, Tao Y, et al: Tissue metabolic profiling
reveals major metabolic alteration in colorectal cancer. Mol Omics.
17:464–471. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai Y, Rattray NJW, Zhang Q, Mironova V,
Santos-Neto A, Muca E, Vollmar AKR, Hsu KS, Rattray Z, Cross JR, et
al: Tumor tissue-specific biomarkers of colorectal cancer by
anatomic location and stage. Metabolites. 10:2572020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao P, Zhou C, Zhao L, Zhang G and Zhang
Y: Tissue amino acid profile could be used to differentiate
advanced adenoma from colorectal cancer. J Pharm Biomed Anal.
118:349–355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirayama A, Kami K, Sugimoto M, Sugawara
M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, et
al: Quantitative metabolome profiling of colon and stomach cancer
microenvironment by capillary electrophoresis time-of-flight mass
spectrometry. Cancer Res. 69:4918–4925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Romisch-Margl W, Prehn C, Bogumil R,
Röhring C, Suhre K and Adamski J: Procedure for tissue sample
preparation and metabolite extraction for high-throughput targeted
metabolomics. Metabolomics. 8:133–142. 2012. View Article : Google Scholar
|
|
20
|
Xu Y, Wang X, Han D, Wang J, Luo Z, Jin T,
Shi C, Zhou X, Lin L and Shan J: Revealing the mechanism of Jiegeng
decoction attenuates bleomycin-induced pulmonary fibrosis via
PI3K/Akt signaling pathway based on lipidomics and transcriptomics.
Phytomedicine. 102:1542072022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao Y, Liu H, Li H, Liu Q, Lu Q, Varshney
RK, Chen X and Honget Y: Widely targeted metabolomics characterizes
the dynamic changes of chemical profile in postharvest peanut
sprouts grown under the dark and light conditions. Food Sci
Technol. 152:1122832021.
|
|
22
|
McCann A, Midttun Ø, Whitfield KC, Kroeun
H, Borath M, Sophonneary P, Ueland PM and Green TJ: Comparable
performance characteristics of plasma thiamine and erythrocyte
thiamine diphosphate in response to thiamine fortification in rural
cambodian women. Nutrients. 9:6762017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chekulayev V, Mado K, Shevchuk I, Koit A,
Kaldma A, Klepinin A, Timohhina N, Tepp K, Kandashvili M, Ounpuu L,
et al: Metabolic remodeling in human colorectal cancer and
surrounding tissues: Alterations in regulation of mitochondrial
respiration and metabolic fluxes. Biochem Biophys Rep. 4:111–125.
2015.PubMed/NCBI
|
|
25
|
Satoh K, Yachida S, Sugimoto M, Oshima M,
Nakagawa T, Akamoto S, Tabata S, Saitoh K, Kato K, Sato S, et al:
Global metabolic reprogramming of colorectal cancer occurs at
adenoma stage and is induced by MYC. Proc Natl Acad Sci USA.
114:E7697–E7706. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goedert JJ, Sampson JN, Moore SC, Xiao Q,
Xiong X, Hayes RB, Ahn J, Shi J and Sinha R: Fecal metabolomics:
Assay performance and association with colorectal cancer.
Carcinogenesis. 35:2089–2096. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stretch C, Eastman T, Mandal R, Eisner R,
Wishart DS, Mourtzakis M, Prado CM, Damaraju S, Ball RO, Greiner R
and Baracos VE: Prediction of skeletal muscle and fat mass in
patients with advanced cancer using a metabolomic approach. J Nutr.
142:14–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vettore L, Westbrook RL and Tennant DA:
New aspects of amino acid metabolism in cancer. Br J Cancer.
122:150–156. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mishra AK, Choi J, Choi SJ and Baek KH:
Cyclodipeptides: An overview of their biosynthesis and biological
activity. Molecules. 22:17962017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mima K, Nishihara R, Qian ZR, Cao Y,
Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al:
Fusobacterium nucleatum in colorectal carcinoma tissue and patient
prognosis. Gut. 65:1973–1980. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng Y, Ling Z and Li L: The intestinal
microbiota and colorectal cancer. Front Immunol. 11:6150562020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sharon I, Grogg M, Hilvert D and Schmeing
TM: Structure and Function of the β-Asp-Arg Polymerase Cyanophycin
Synthetase 2. ACS Chem Biol. 17:670–679. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Santos CR and Schulze A: Lipid metabolism
in cancer. FEBS J. 279:2610–2623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao Z, Xiao Y, Elson P, Tan H, Plummer
SJ, Berk M, Aung PP, Lavery IC, Achkar JP, Li L, et al: Plasma
lysophosphatidylcholine levels: Potential biomarkers for colorectal
cancer. J Clin Oncol. 25:2696–2701. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Console L, Scalise M, Mazza T, Pochini L,
Galluccio M, Giangregorio N, Tonazzi A and Indiveri C: Carnitine
traffic in cells. Link with cancer. Front Cell Dev Biol.
8:5838502020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang F, Zhang Y, Zhao W, Deng K, Wang Z,
Yang C, Ma L, Openkova MS, Hou Y and Li K: Metabolomics for
biomarker discovery in the diagnosis, prognosis, survival and
recurrence of colorectal cancer: A systematic review. Oncotarget.
8:35460–35472. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dionne S, Elimrani I, Roy MJ, Qureshi IA,
Sarma DR, Levy E and Seidman EG: Studies on the chemopreventive
effect of carnitine on tumorigenesis in vivo, using two
experimental murine models of colon cancer. Nutr Cancer.
64:1279–1287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun Y, Liu B, Chen Y, Xing Y and Zhang Y:
Multi-Omics prognostic signatures based on lipid metabolism for
colorectal cancer. Front Cell Dev Biol. 9:8119572021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kurabe N, Hayasaka T, Ogawa M, Masaki N,
Ide Y, Waki M, Nakamura T, Kurachi K, Kahyo T, Shinmura K, et al:
Accumulated phosphatidylcholine (16:0/16:1) in human colorectal
cancer; possible involvement of LPCAT4. Cancer Sci. 104:1295–1302.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pakiet A, Kobiela J, Stepnowski P,
Sledzinski T and Mika A: Changes in lipids composition and
metabolism in colorectal cancer: A review. Lipids Health Dis.
18:292019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma J, Zhong M, Xiong Y, Gao Z, Wu Z, Liu Y
and Hong X: Emerging roles of nucleotide metabolism in cancer
development: Progress and prospect. Aging. 13:13349–13358. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lane AN and Fan TW: Regulation of
mammalian nucleotide metabolism and biosynthesis. Nucleic Acids
Res. 43:2466–2485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Haziman AA, Ravinderan S, Thangavelu T and
Thomas W: A novel role for estrogen-induced signaling in the
colorectal cancer gender bias. Ir J Med Sci. 188:389–395. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ditonno I, Losurdo G, Rendina M, Pricci M,
Girardi B, Ierardi E and Di Leo A: Estrogen receptors in colorectal
cancer: Facts, novelties and perspectives. Curr Oncol.
28:4256–4263. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Caiazza F, Ryan EJ, Doherty G, Winter DC
and Sheahan K: Estrogen receptors and their implications in
colorectal carcinogenesis. Front Oncol. 5:192015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Langner E, Jeleniewicz W, Turski WA and
Plech T: Quinaldic acid induces changes in the expression of p53
tumor suppressor both on protein and gene level in colon cancer
LS180 cells. Pharmacol Rep. 71:189–193. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Langner E, Walczak K, Jeleniewicz W,
Turski WA and Rajtar G: Quinaldic acid inhibits proliferation of
colon cancer ht-29 cells in vitro: Effects on signaling pathways.
Eur J Pharmacol. 757:21–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Perei K, Rakhely G, Kiss I, Polyák B and
Kovács KL: Biodegradation of sulfanilic acid by Pseudomonas
paucimobilis. Appl Microbiol biotechnol. 55:101–107. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Baxter BA, Parker KD, Nosler MJ, Rao S,
Craig R, Seiler C and Ryan EP: Metabolite profile comparisons
between ascending and descending colon tissue in healthy adults.
World J Gastroenterol. 26:335–352. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wong MCS, Huang J, Lok V, Wang J, Fung F,
Ding H and Zheng ZJ: Differences in incidence and mortality trends
of colorectal cancer worldwide based on sex, age, and anatomic
location. Clin Gastroenterol Hepatol. 19:955–966.e61. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mirnezami R, Jimenez B, Li JV, Kinross JM,
Veselkov K, Goldin RD, Holmes E, Nicholson JK and Darzi A: Rapid
diagnosis and staging of colorectal cancer via high-resolution
magic angle spinning nuclear magnetic resonance (HR-MAS NMR)
spectroscopy of intact tissue biopsies. Ann Surg. 259:1138–1149.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jimenez B, Mirnezami R, Kinross J, Cloarec
O, Keun HC, Holmes E, Goldin RD, Ziprin P, Darzi A and Nicholson
JK: 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic
‘field-effects’ enables colorectal cancer staging and
prognostication. J Proteome Res. 12:959–968. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tian JS, Xue WN, Yin HH, Zhang N, Zhou J,
Long Z, Wu C, Liang Z, Xie K, Li S, et al: Differential metabolic
alterations and biomarkers between gastric cancer and colorectal
cancer: A systematic review and meta-analysis. Onco Targets Ther.
13:6093–6108. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kosmides AK, Kamisoglu K, Calvano SE,
Corbett SA and Androulakis IP: Metabolomic fingerprinting:
Challenges and opportunities. Crit Rev Biomed Eng. 41:205–221.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yusof HM, Ab-Rahim S, Suddin LS, Saman MSA
and Mazlan M: Metabolomics profiling on different stages of
colorectal cancer: A systematic review. Malays J Med Sci. 25:16–34.
2018.PubMed/NCBI
|
|
56
|
Long Z, Zhou J, Xie K, Wu Z, Yin H, Daria
V, Tian J, Zhang N, Li L, Zhao Y, et al: Metabolomic markers of
colorectal tumor with different clinicopathological features. Front
Oncol. 10:9812020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Manna SK, Tanaka N, Krausz KW, Haznadar M,
Xue X, Matsubara T, Bowman ED, Fearon ER, Harris CC, Shah YM and
Gonzalez FJ: Biomarkers of coordinate metabolic reprogramming in
colorectal tumors in mice and humans. Gastroenterology.
146:1313–1324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shen X, Cai Y, Lu L, Huang H, Yan H, Paty
PB, Muca E, Ahuja N, Zhang Y, Johnson CH and Khan SA: Asparagine
metabolism in tumors is linked to poor survival in females with
colorectal cancer: A cohort study. Metabolites. 12:1642022.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ong ES, Zou L, Li S, Cheah PY, Eu KW and
Ong CN: Metabolic profiling in colorectal cancer reveals signature
metabolic shifts during tumorigenesis. Mol Cell Proteomics. Feb
10–2010.doi: 10.1074/mcp.M900551-MCP200 (Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Li Z, Deng X, Luo J, Lei Y, Jin X, Zhu J
and Lv G: Metabolomic comparison of patients with colorectal cancer
at different anticancer treatment stages. Front Oncol.
11:5743182021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Brown DG, Rao S, Weir TL, O'Malia J, Bazan
M, Brown RJ and Ryan EP: Metabolomics and metabolic pathway
networks from human colorectal cancers, adjacent mucosa, and stool.
Cancer Metab. 4:112016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liesenfeld DB, Habermann N, Toth R, Owen
RW, Frei E, Staffa J, Schrotz-King P, Klika KD and Ulrich CM:
Changes in urinary metabolic profiles of colorectal cancer patients
enrolled in a prospective cohort study (ColoCare). Metabolomics.
11:998–1012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Udo R, Katsumata K, Kuwabara H, Enomoto M,
Ishizaki T, Sunamura M, Nagakawa Y, Soya R, Sugimoto M and Tsuchida
A: Urinary charged metabolite profiling of colorectal cancer using
capillary electrophoresis-mass spectrometry. Sci Rep. 10:210572020.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Williams MD, Zhang X, Park JJ, Siems WF,
Gang DR, Resar LM, Reeves R and Hill HH Jr: Characterizing
metabolic changes in human colorectal cancer. Anal Bioanal Chem.
407:4581–4595. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang Y, Hinz S, Uckermann O, Hönscheid P,
von Schönfels W, Burmeister G, Hendricks A, Ackerman JM, Baretton
GB, Hampe J, et al: Shotgun lipidomics-based characterization of
the landscape of lipid metabolism in colorectal cancer. Biochim
Biophys Acta Mol Cell Biol Lipids. 1865:1585792020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shen S, Yang L, Li L, Bai Y, Cai C and Liu
H: A plasma lipidomics strategy reveals perturbed lipid metabolic
pathways and potential lipid biomarkers of human colorectal cancer.
J Chromatogr B Analyt Technol Biomed Life Sci. 1068–1069. 41–48.
2017.PubMed/NCBI
|
|
67
|
Cai Y, Rattray NJW, Zhang Q, Mironova V,
Santos-Neto A, Hsu KS, Rattray Z, Cross JR, Zhang Y, Paty PB, et
al: Sex differences in colon cancer metabolism reveal a novel
subphenotype. Sci Rep. 10:49052020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ecker J, Benedetti E, Kindt ASD, Höring M,
Perl M, Machmüller AC, Sichler A, Plagge J, Wang Y, Zeissig S, et
al: The colorectal cancer lipidome: Identification of a robust
Tumor-Specific lipid species signature. Gastroenterology.
161:910–923.e19. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kuhn T, Floegel A, Sookthai D, Johnson T,
Rolle-Kampczyk U, Otto W, von Bergen M, Boeing H and Kaaks R:
Higher plasma levels of lysophosphatidylcholine 18:0 are related to
a lower risk of common cancers in a prospective metabolomics study.
BMC Med. 14:132016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Holowatyj AN, Gigic B, Herpel E, Scalbert
A, Schneider M and Ulrich CM; MetaboCCC Consortium; ColoCare Study,
: Distinct molecular phenotype of sporadic colorectal cancers among
young patients based on multiomics analysis. Gastroenterology.
158:1155–1158.e2. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zarei I, Baxter BA, Oppel RC, Borresen EC,
Brown RJ and Ryan EP: Plasma and urine metabolite profiles impacted
by increased dietary navy bean intake in colorectal cancer
survivors: A randomized-controlled trial. Cancer Prev Res (Phila).
14:497–508. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lin L, Zeng X, Liang S, Wang Y, Dai X, Sun
Y and Wu Z: Biomarkers of coordinate metabolic reprogramming and
the construction of a co-expression network in colorectal cancer.
Ann Transl Med. 10:11152022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li M, Wu S, Zhuang C, Shi C, Gu L, Wang P,
Guo F, Wang Y and Liu Z: Metabolomic analysis of circulating tumor
cells derived liver metastasis of colorectal cancer. Heliyon.
9:e125152023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Montrose DC, Zhou XK, Kopelovich L,
Yantiss RK, Karoly ED, Subbaramaiah K and Dannenberg AJ: Metabolic
profiling, a noninvasive approach for the detection of experimental
colorectal neoplasia. Cancer Prev Res (Phila). 5:1358–1367. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yoshie T, Nishiumi S, Izumi Y, Sakai A,
Inoue J, Azuma T and Yoshida M: Regulation of the metabolite
profile by an APC gene mutation in colorectal cancer. Cancer Sci.
103:1010–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Long Y, Sanchez-Espiridion B, Lin M, White
L, Mishra L, Raju GS, Kopetz S, Eng C, Hildebrandt MAT, Chang DW,
et al: Global and targeted serum metabolic profiling of colorectal
cancer progression. Cancer. 123:4066–4074. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Luo Z, Wang H, Lin S, Liao L, Cai L, Zhang
X, Tan Y and Shen M: Study on the levels of N-nitrosamine compounds
and untargeted metabolomics in patients with colorectal cancer.
Anal Bioanal Chem. 414:3483–3496. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yang F, DeLuca JAA, Menon R,
Garcia-Vilarato E, Callaway E, Landrock KK, Lee K, Safe SH, Chapkin
RS, Allred CD and Jayaraman A: Effect of diet and intestinal AhR
expression on fecal microbiome and metabolomic profiles. Microb
Cell Fact. 19:2192020. View Article : Google Scholar : PubMed/NCBI
|
